Thomas DL - Search Results

1

Public health clinic-based hepatitis C testing and linkage to care in Baltimore.

Falade-Nwulia O, Mehta SH, Lasola J, Latkin C, Niculescu A, O'Connor C, Chaulk P, Ghanem K, Page KR, Sulkowski MS, Thomas DL. Falade-Nwulia O, et al. Among authors: thomas dl. J Viral Hepat. 2016 May;23(5):366-74. doi: 10.1111/jvh.12507. Epub 2016 Feb 3. J Viral Hepat. 2016. PMID: 26840570 Free PMC article.

2

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships.

Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. Thomas DL, et al. J Infect Dis. 1995 Apr;171(4):768-75. doi: 10.1093/infdis/171.4.768. J Infect Dis. 1995. PMID: 7535827

3

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.

Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC. Thomas DL, et al. Arch Intern Med. 1993 Jul 26;153(14):1705-12. Arch Intern Med. 1993. PMID: 8333808

4

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Villano SA, et al. Among authors: thomas dl. J Clin Microbiol. 1997 Dec;35(12):3274-7. doi: 10.1128/jcm.35.12.3274-3277.1997. J Clin Microbiol. 1997. PMID: 9399533 Free PMC article.

5

Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Garfein RS, et al. Among authors: thomas dl. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S11-9. doi: 10.1097/00042560-199802001-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9663618

6

Hepatitis C epidemiology.

Thomas DL. Thomas DL. Curr Top Microbiol Immunol. 2000;242:25-41. doi: 10.1007/978-3-642-59605-6_2. Curr Top Microbiol Immunol. 2000. PMID: 10592654 Review.

7

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: thomas dl. JAMA. 2000 Jan 5;283(1):74-80. doi: 10.1001/jama.283.1.74. JAMA. 2000. PMID: 10632283

8

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Among authors: thomas dl. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

9

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Ann Intern Med. 2000 Oct 17;133(8):592-9. doi: 10.7326/0003-4819-133-8-200010170-00009. Ann Intern Med. 2000. PMID: 11033586

10

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Mehta SH, et al. Among authors: thomas dl. Hepatology. 2001 Jun;33(6):1554. doi: 10.1053/jhep.2001.0103306le01. Hepatology. 2001. PMID: 11391549 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

752 results

Search Page